100% Response Rate in Skin Cancer Trial

Posted by & filed under Uncategorized.

Our West family is 1 of only 2 sites across the country to host this clinical trial for patients with recurrent or unresectable skin cancers. “After 12 weeks post-treatment, complete response was observed in all 10 patients (100%)! CT scans at 24 weeks post-treatment showed NO EVIDENCE OF RECURRENT DISEASE in any of the patients.”… Read more »

West Seeks Patients with Breast Cancer Undergoing Lumpectomy Surgery for Clinical Trial Using Investigational Imaging Technology with Artificial Intelligence (AI)

Posted by & filed under Uncategorized.

Study Will Assess Impact on Positive Margin Rates West Cancer Center is seeking patients with breast cancer who are undergoing breast-conserving surgery, or a “lumpectomy,” for potential participation in a clinical trial. Dr. Richard Fine, Dr. Michael Berry, and Dr. Richard Gilmore are the breast surgeons participating in this trial. Breast Surgeon, Dr. Richard Fine,… Read more »

Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute’s Ari Vanderwalde, MD, MPH is a SWOG (a National Cancer Institute supported organization that conducts clinical trials in adults) investigator and study chair for a trial that addresses advanced melanoma patients who are resistant to PD-1 inhibitors. Over 40% of these patients don’t respond to PD-1 inhibitors, widely used… Read more »

New Breast Conservation Surgery Clinical Trial

Posted by & filed under Uncategorized.

Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee Pivotal study to determine the impact of Perimeter B-Series OCT with ImgAssist AI on positive margin rates during breast conservation surgery    Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery… Read more »

West’s Director of Research Participated in the Clinical Trials for a COVID-19 Vaccine

Posted by & filed under Uncategorized.

Ari VanderWalde, MD, MPH, Bioeth, West Cancer Center and Research Institute’s Director of Research, stands behind the safety and highly regulated protocols for participants in clinical trials. Dr. VanderWalde recognized the importance and urgency to create a safe and effective vaccine to combat COVID-19. “I had a 50% chance of getting the vaccine and 50%… Read more »

Dr. Gregory Vidal Discusses Use of Patient Registries in Neratinib Study

Posted by & filed under Uncategorized.

Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer.   Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »